New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

Reduced-dose radiotherapy in head & neck cancer shows similar efficacy to standard dose but with lower toxicity, per findings ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

A doctor at Monday’s event said some of the reasons for Iowa’s increased cancer rate include HPV, alcohol use, and the state’s higher obesity rate.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

In an exclusive excerpt from her new book, Suleika Jaouad reflects on how the devastating effects of the disease changed her ...

Pembrolizumab alone or in combination with chemotherapy can provide long-term benefits over chemotherapy alone in recurrent or metastatic HNSCC, data suggest.